Research & Innovation
What is the latest research on medulloblastoma?
We are conducting numerous research studies that will help clinicians better understand and treat medulloblastoma. For more information on current research, see the Brain Tumor Program.
Recently, scientists have discovered the molecular characteristics of medulloblastomas, identifying several subtypes, which may be correlated with prognosis. In the future, these discoveries may help researchers to develop better therapies.
It is possible that your child will be eligible to participate in one of Children’s current clinical trials. These studies are useful for a multitude of reasons: Some trials are designed to evaluate the effectiveness of a particular drug, treatment or therapy for a specific disease; others help doctors to better understand how and why certain conditions occur. At any given time, Children’s has hundreds of clinical trials underway.
To search current and upcoming clinical trials at Children’s, go to our Clinical Trials Page.
To search for a cancer trial at Dana-Farber/Children’s Hospital Cancer Center, go here.
To search the NIH’s list of clinical trials taking place around the world, go here.
|What makes a medulloblastoma a medulloblastoma?|
|Not all medulloblastomas—the most common malignant childhood brain tumor —are the same, but for years we haven't known why or what that meant in terms of patient care. Armed with next generation gene sequencing technologies, Boston Children's Neurologist-in-Chief Scott Pomeroy, MD, PhD, may have found the answer. Learn more|
|Find out more about the innovative clinical trials available at the Dana-Farber/Children’s Hospital Cancer Center .|